As per MRFR Analysis, the Global Syringes Market was valued at 5.79 USD Billion in 2023 and is projected to grow to 10.2 USD Billion by 2035, reflecting a CAGR of 4.82% from 2025 to 2035. The market is driven by increasing vaccination demands, technological advancements in syringe manufacturing, and the rising prevalence of chronic diseases. The COVID-19 pandemic has further accelerated the need for disposable syringes, leading to heightened production capacities, especially in low- and middle-income countries.
The Global Syringes Market is witnessing transformative trends that enhance healthcare delivery.
Nipro Corporation; Becton Dickinson and Company; Sarstedt AG and Co. KG; Owen Mumford; Dynarex Corporation; Terumo Corporation; Smiths Medical; Retractable Technologies; Medtronic; Braun Melsungen AG.
The Syringes Market is currently undergoing substantial trends that are being driven by a variety of factors. The demand for vaccination is on the rise as public health initiatives expand ly, particularly in response to recent health crises. This is a significant market driver. The proliferation of chronic diseases further exacerbates the necessity for effective drug delivery solutions. Additionally, the implementation of safety features in syringe design, such as those that prevent needlestick injuries, is becoming increasingly critical in order to address safety concerns among healthcare professionals, thanks to technological advancements. This market offers a plethora of opportunities, particularly in developing regions where healthcare infrastructure is improving.
The growing population and the rising prevalence of diabetes and other long-term conditions facilitate the expansion of syringe utilization. Furthermore, manufacturers who are seeking to innovate and adapt to a changing market are presented with a lucrative opportunity by the advancement of automated and intelligent syringes. In recent years, there has been an increase in the prevalence of pre-filled syringes. This syringe is designed to reduce the danger of contamination and improve the user experience for patients. Moreover, the emphasis on eco-friendly materials and sustainability is becoming more significant. Companies are being compelled to reconsider their product designs as a result of the increasing prevalence of disposable and recyclable syringes, which are being promoted by policies in an effort to mitigate the environmental impact.
The incorporation of digital technology in syringes, such as features that monitor medication adherence, is also on the rise, suggesting a transition to more patient-centric healthcare solutions.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The Syringes Market is greatly driven by advancements in medical technology, particularly innovations in syringe design and materials. For instance, the introduction of safety syringes has been a significant development, enhancing patient safety and minimizing needlestick injuries. According to the World Health Organization, needlestick injuries account for approximately 1 million injuries among health care workers each year, highlighting the urgency for safer syringe designs.
Companies such as Becton, Dickinson and Company are at the forefront of these innovations, continually investing in Research and Development to enhance product safety and usability. The shift towards automation and precision medicine also encourages the adoption of technologically advanced syringes, further fueling market growth. As healthcare sectors worldwide increase their investments in advanced medical technologies, the demand for sophisticated syringe solutions is expected to rise, pushing the Syringes Market forward significantly.
The increasing incidence of chronic diseases, including diabetes and cardiovascular diseases, is a notable driver for the Syringes Market. According to the World Health Organization, the prevalence of diabetes has nearly quadrupled since 1980, with an estimated 422 million adults suffering from the condition in 2014. This figure is expected to rise, leading to greater demand for insulin syringes and other medical syringes necessary for chronic disease management.
Established organizations in the pharmaceutical sector, such as Novo Nordisk, are focusing efforts on developing effective diabetic care solutions and require various types of syringes to administer treatments. The rising need for convenient at-home delivery of medications will also contribute significantly to the demand for syringes and drive the growth of the Syringes Market.
The expanded vaccination programs ly, notably accelerated by the COVID-19 pandemic, represent a significant driver for the Syringes Market Industry. Governments and health organizations across the globe have mobilized extensive resources to vaccinate populations efficiently. For example, data from the World Health Organization indicates that over 12 billion vaccine doses were administered worldwide by the end of 2021, demonstrating the surge in demand for syringes.
Prominent manufacturers like Terumo Corporation have ramped up production to meet this unprecedented demand while ensuring the quality and reliability of their products. The continuous push towards preventive healthcare and routine immunization programs further illustrates how critical syringes are to current public health strategies, thus propelling the Syringes Market growth.
The Syringes Market is diversified into several types that play critical roles in healthcare, greatly influencing patient care and treatment methodologies. In 2024, the market value for hypodermic syringes is noted to be 2.41 USD billion, securing a dominant position within the overall market landscape. Hypodermic syringes serve as essential tools for administering medication and vaccines, which is significant in light of recent health initiatives aimed at increasing immunization rates. Following this, insulin syringes are anticipated to reach a market value of 1.18 USD billion in the same year, reflecting the critical need for diabetes management, a condition that affects millions globally.
The increasing prevalence of diabetes and the push for effective chronic disease management underscore the significance of this syringe type in the healthcare system. Safety syringes, valued at 1.52 USD billion in 2024, are gaining traction due to heightened awareness around the prevention of needlestick injuries among healthcare workers, which speaks to the growing importance of safety features in medical devices. These syringes are designed to mitigate risks, thereby enhancing workplace safety and compliance with regulations aimed at protecting healthcare professionals.
Pre-filled syringes represent another important segment with a valuation of 1.96 USD billion in 2024. The convenience and reduced risk of dosing errors associated with pre-filled syringes support their growing popularity, particularly in outpatient settings and home healthcare, where self-administration is increasingly required. As a result, pre-filled syringes present significant opportunities for market growth driven by advances in pharmaceutical delivery systems. Overall, these segmented insights into the Syringes Market outline a diverse landscape, wherein each type is interconnected with health trends, thereby showcasing their importance and demand within the broader context of healthcare provision.
The increased focus on safety and convenience in the design of syringes is anticipated to drive innovation and growth across these types, as the healthcare industry continues evolving to meet the demands of an aging population and the prevalence of chronic conditions. The combined market statistics within the Type segment reflect substantial opportunities for development, investment, and technological advancements in the coming years, as they serve critical roles in patient treatment and care across the globe.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The Syringes Market revenue has been on a steady rise, with the market expected to be valued at 6.07 USD billion in 2024 and projected to reach 10.2 USD billion by 2035. The segmentation within the Material category highlights a variety of components, including Plastic, Glass, and Metal, each contributing uniquely to the market dynamics. Plastic syringes dominate the market due to their lightweight nature and cost-effectiveness, making them widely adopted in various healthcare settings. Glass syringes are valued for their chemical resistance and precision, making them preferable in situations demanding high sterility and accuracy.
Metal syringes, though less common, find their niche in specialized applications. The driving forces behind market growth encompass advancements in healthcare technology, rising demand for safe and sterile injection devices, and the increasing prevalence of chronic diseases necessitating regular medication. However, challenges such as the rising concern over environmental sustainability, particularly in disposable plastic syringes, are influencing market strategies. Prospects remain positive as manufacturers innovate towards eco-friendly solutions.
These trends collectively shape the Syringes Market statistics, revealing evolving consumer preferences and regulatory landscapes impacting the industry at large.
The Syringes Market has been demonstrating notable growth, particularly within the Usage segment, which encompasses both Single Use and Multi Use categories. By 2024, the overall market is expected to reach a value of 6.07 billion USD, showcasing rising demand and applications. Single-use syringes are becoming increasingly essential in healthcare settings due to their ability to reduce the risk of cross-contamination and ensure patient safety, thus significantly contributing to their predominance in the market. On the other hand, multi-use syringes are valued for their cost-effectiveness and utility in settings where multiple injections are necessary, highlighting the diverse preferences of healthcare providers.
The Syringes Market segmentation reflects the diverse requirements of the healthcare industry, driven by factors such as the growing prevalence of chronic diseases, vaccination drives, and the rising focus on safety standards. Challenges like regulatory requirements and the need for sterile production processes can impact market dynamics. However, the market is also poised for opportunities in technological advancements and innovations, further enhancing the usability and functionality of syringes in a context.
The Syringes Market exhibits diverse applications across various end-use segments, contributing significantly to its overall growth. By 2024, the market is expected to reach a valuation of 6.07 USD billion, with hospitals, clinics, and home care settings being key areas of utilization. Hospitals play a crucial role in the demand for syringes due to their essential function in inpatient care and surgical procedures, while clinics contribute by providing outpatient care, vaccination programs, and routine medical treatments. The home care segment is witnessing increased attention, as more patients are receiving treatments at home, driving the need for user-friendly syringes.
Notably, the rising prevalence of chronic illnesses and the growing preference for minimally invasive procedures are major growth drivers impacting these end-use segments. Challenges such as stringent regulatory frameworks and the need for advanced safety features to prevent needlestick injuries also shape the landscape. Overall, the Syringes Market segmentation indicates a strong potential for growth, primarily fueled by the incorporation of technology in health care and evolving patient preferences for home-based treatment solutions.
The Syringes Market demonstrates diverse regional dynamics, with an overall valuation of 6.07 USD billion in 2024. North America stands out with significant market revenue of 2.45 USD billion, which is expected to grow to 4.05 USD billion by 2035, highlighting its majority holding in the market due to advanced healthcare infrastructure and high demand for medical devices. Europe follows closely with a valuation of 1.8 USD Billion in 2024, anticipated to reach 2.9 USD billion by 2035, supported by stringent regulatory frameworks and a growing emphasis on patient safety.
The Asia Pacific region also plays a crucial role, valued at 1.8 USD Billion in 2024 and projected to grow to 2.9 USD billion by 2035, owing to rapid urbanization and increasing healthcare expenditures. South America presents a smaller market size with a value of 0.45 USD billion in 2024, expected to grow to 0.7 USD billion by 2035, while the Middle East and Africa capture 0.57 USD billion in 2024, growing to 0.75 USD billion by the same year. Overall, the Syringes Market data underscores the significance of these regional segments in driving market growth, with North America and Europe leading due to robust healthcare systems and evolving patient needs.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The Syringes Market is characterized by a competitive landscape that encompasses various players focused on innovation, market penetration, and expanding their product offerings. As the demand for syringes continues to rise, driven by growing healthcare needs, advancements in medical technology, and an increasing emphasis on patient safety, companies within this market are leveraging their strengths to capture a larger share. The presence of numerous manufacturers and suppliers has led to a diverse range of products, catering to different medical applications such as vaccinations, infusion therapies, and drug delivery systems. This competitive landscape is not only shaped by the quality and effectiveness of syringes but also by strategic partnerships, geographical reach, and compliance with regulatory standards that facilitate market growth across various regions.
Schott AG stands out in the Syringes Market with its robust reputation for high-quality glass packaging solutions and innovative syringe technologies. The company's strengths include its extensive experience in materials science and pharmaceutical packaging, which allows it to produce syringes that meet stringent safety and quality standards. With a strong presence, Schott AG benefits from advanced manufacturing capabilities and a commitment to research and development that helps drive innovation in design and functionality. The company has positioned itself as a reliable partner for pharmaceutical manufacturers by supplying sophisticated syringe systems that enhance medication delivery and improve patient outcomes. Schott AG’s focus on sustainability and compliance with international regulations further strengthens its market position and appeal among healthcare providers.
Unilife Corporation is another key player in the Syringes Market, known for its innovative safety-engineered syringes designed to minimize the risk of needlestick injuries. The company's offerings are centered around specialized syringe systems that integrate advanced technologies for ease of use and enhanced safety. Unilife Corporation maintains a significant market presence through strategic collaborations with pharmaceutical companies, ensuring that its products meet the growing demand for safe and efficient drug delivery solutions. Its strengths lie in the ability to rapidly develop and customize syringe solutions tailored to specific market needs, underpinned by a commitment to quality and efficiency. Unilife's ongoing efforts in mergers and acquisitions enhance its capabilities and market reach, allowing it to respond effectively to evolving industry trends and regulatory challenges in the healthcare sector.
The Syringes Market has witnessed significant developments recently, primarily driven by the surge in demand for vaccines and insulin delivery systems. Companies like Becton Dickinson and Company and Terumo Corporation are enhancing their manufacturing processes to increase capacity.
BD announced in January 2025 that it would invest an additional wave of capital in its U.S. manufacturing network to increase the capacity of syringes, needles, and IV catheters.
BD announced in July 2024 that it would invest an additional generation of capital in its U.S. manufacturing network to increase the capacity of syringes, needles, and IV catheters.
Hindustan Syringes & Medical Devices introduced Dispojekt single-use syringes in India in March 2024.
Additionally, ongoing partnerships among leading companies like Hindustan Syringes and Medical Devices and ConvaTec Group have been reported, aiming to enhance product offerings in response to health challenges. Over the past two years, the emphasis on safety and efficiency in syringe production has become paramount, especially as the healthcare landscape evolves.
| Report Attribute/Metric | Details |
| Market Size 2023 | 5.79(USD Billion) |
| Market Size 2024 | 6.07(USD Billion) |
| Market Size 2035 | 10.2(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 4.83% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Schott AG, Unilife Corporation, Fresenius Kabi, Smiths Medical, Hollyland Technology, Syringe Factory, Gerresheimer AG, NIPRO Corporation, Weigao Group, Medtronic, ConvaTec Group, Cardinal Health, Hindustan Syringes and Medical Devices, Becton Dickinson and Company, Terumo Corporation |
| Segments Covered | Type, Material, Usage, End Use, Regional |
| Key Market Opportunities | Rising demand for insulin syringes, Growth in vaccinations and immunizations, Increased home healthcare services, Technological advancements in syringe design, Expanding geriatric population needing care |
| Key Market Dynamics | increasing demand for vaccinations, rise in chronic diseases, technological advancements in syringes, growing home healthcare market, and regulatory support for safety devices |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Syringes Market Highlights:
Frequently Asked Questions (FAQ) :
The Syringes Market is expected to be valued at 6.07 USD billion in 2024.
The Syringes Market is expected to grow at a CAGR of 4.83% from 2025 to 2035.
North America is expected to dominate the Syringes Market with a value of 2.45 USD billion in 2024.
The market value of Safety Syringes is projected to reach 2.51 USD Billion in 2035.
Major players in the Syringes Market include Becton Dickinson and Company, Medtronic, and Fresenius Kabi.
Insulin Syringes are expected to have a market value of 1.18 USD billion in 2024.
The Syringes Market is expected to reach a valuation of 10.2 USD billion by 2035.
Pre-filled Syringes are projected to have a market value of 1.96 USD billion in 2024.
The Asia Pacific region is anticipated to grow significantly, reaching 2.9 USD billion by 2035.
Hypodermic Syringes are expected to have a market value of 4.03 USD billion in 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager - Research High acumen in analyzing complex macro & micro markets with more than 6 years of work experience in the field of market research. by implementing her analytical skills in forecasting and estimation into market research reports, she has expertise in packaging, construction, and equipment domains. she handles a team size of 20-25 resources and ensures smooth running of the projects, associated marketing activities, and client servicing.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
